In answer to your question I would suggest simply contacting BOD members,
especially Dr. Lars Ekman, AMRN's COB. Another suggestion would be to
have an attorney (Marjac?) get two proposals placed on AMRN's Proxy
for a vote:
1. Suggest the company hire an investment bank to sell the company.
2. Suggest the CEO be replaced.
In reality this is unlikely, but what I hope it would lead to is a
dialogue between Marjac and Dr. Ekman to discuss shareholder concerns.
It would, however, help get our message across.